Article Versions Notes

Myint ZW, St. Clair WH, Strup SE, Yan D, Li N, Allison DB, McLouth LE, Ellis CS, Wang P, James AC, et al. A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer. Cancers. 2023; 15(9):2505. https://doi.org/10.3390/cancers15092505

Myint, Zin W., William H. St. Clair, Stephen E. Strup, Donglin Yan, Ning Li, Derek B. Allison, Laurie E. McLouth, Carleton S. Ellis, Peng Wang, Andrew C. James, and et al. 2023. "A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer" Cancers 15, no. 9: 2505. https://doi.org/10.3390/cancers15092505

Myint, Z. W., St. Clair, W. H., Strup, S. E., Yan, D., Li, N., Allison, D. B., McLouth, L. E., Ellis, C. S., Wang, P., James, A. C., Hensley, P. J., Otto, D. E., Arnold, S. M., DiPaola, R. S., & Kolesar, J. M. (2023). A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer. Cancers, 15(9), 2505. https://doi.org/10.3390/cancers15092505